Searchable abstracts of presentations at key conferences in endocrinology

ea0041s6.3 | Characterization and treatment of thyroid cancer | ECE2016

Dynamic risk stratification in the follow up of thyroid cancer

Jarzab Barbara

The discussion which prognostic factors are the most reliable to adequately assess the risk of cancer related death and relapse in differentiated thyroid cancers [DTC] is ongoing. To date, age at diagnosis and distant metastases were considered as the most important risk factors. Among other factors, that may influence both overall and disease free survival, were male sex, some histopathological features such as: tumor diameter, tumor grade, aggressive histotype, extrathyroida...

ea0016s27.3 | Nodules and more: new aspects of thyroid disorders | ECE2008

Therapeutic options and dilemmas in medullary thyroid carcinoma

Jarzab Barbara

Analysis of RET germline mutations, now a routine element of diagnostic algorithm in medullary thyroid carcinoma (MTC), influences follow up of MTC patients but at present has less impact on treatment modalities, which are the same in hereditary and sporadic disease. Microarray analyses confirm that molecular profile is rather similar in both MTC forms.In hereditary MTC, RET mutation screening in families at risk allows to find asymptomatic mutation carr...

ea0035p550 | Endocrine tumours and neoplasia | ECE2014

The effectiveness of yttrium90/lutetium177-labeled somatostatin analogues treatment in functional pNETs

Michalik Barbara , Handkiewicz-Junak Daria , Hasse-Lazar Kornelia , Jarzab Barbara

Introduction: Therapy with somatostatin analouges is usually ineffective to remove hormonal symptoms in patients with functional pancreatic neuroendocrine tumors (pNET). Alternative treatment modalities, to control symptoms of excessive hormonal production, are necessary. Thus, the aim of our study was to evaluate results of radiopeptide treatment in patient with functional pNET.Materials and methods: 92 patients with pNET (49 women and 43 men, median ag...

ea0014p367 | (1) | ECE2007

Expression of folate receptor is down-regulated in somatotropinomas

Zebracka Jadwiga , Rudnik Adam , Lazar Kornelia Hasse , Larysz Dawid , Jarzab Michal , Lubieniecka Beata , Gala Grzegorz , Jarzab Barbara

Introduction: Pathogenesis of pituitary adenomas is largely unknown thus, identification of genes specific for various types of pituitary tumors should enable better understanding of their biology.The aim of our study was to analyze differences in gene expression between functional (FA) and non-functional (NFA) pituitary adenomas. For this goal, we considered folate receptor (FOLR1) shown by previous study (Evans et al. 2003) to be overexpr...

ea0037ep904 | Thyroid cancer | ECE2015

Adjuvant radioiodine (RAI) treatment reduces the risk of relapse in low advanced differentiated thyroid carcinoma (DTC)

Krajewska Jolanta , Jarzab Michal , Czarniecka Agnieszka , Kukulska Aleksandra , Handkiewicz-Junak Daria , Wygoda Zbigniew , Puch Zbigniew , Paliczka-Cieslik Ewa , Roskosz Jozef , Jarzab Barbara

The routine use of adjuvant RAI treatment in low-risk DTC remains controversial due to the lack of unequivocal evidences of its effectiveness in radically operated subjects. The aim of the study was a retrospective evaluation of long-term outcomes of combined DTC treatment to evaluate the impact of adjuvant RAI therapy in the low risk group. Primary hypothesis was: ‘if adjuvant RAI treatment was unnecessary, a delay in RAI administration would have no impact on long-term ...

ea0035p1098 | Thyroid Cancer | ECE2014

Risk factors of cancer relapse in differentiated thyroid carcinomas

Krajewska Jolanta , Jarzab Michal , Czarniecka Agnieszka , Roskosz Jozef , Kukulska Aleksandra , Handkiewicz-Junak Daria , Puch Zbigniew , Paliczka-Cieslik Ewa , Wygoda Zbigniew , Jarzab Barbara

Introduction: Reliable prognostic factors are crucial to choose the optimal treatment strategy and follow-up for differentiated thyroid carcinomas (DTC) patients. Thus, the aim of the study was a retrospective evaluation of prognostic factors of cancer relapse in patients treated in a single institution.Material: The study group consisted of 510 DTC patients, staged pT1b-T4N0-N1M0, treated with total thyroidectomy followed by complementary 131...

ea0035p1152 | Thyroid Cancer | ECE2014

Gene expression signature associated with BRAFV600E mutation in human papillary thyroid carcinoma based on transgenic mouse model

Rusinek Dagmara , Swierniak Michal , Chmielik Ewa , Kowal Monika , Kowalska Malgorzata , Czarniecka Agnieszka , Przeorek Cezary , Cyplinska Renata , Jarzab Michal , Widlak Wieslawa , Jarzab Barbara

Objectives: Recent studies on BRAFV600E mutation, known as initiating event in papillary thyroid carcinoma (PTC) and related to more aggressive clinical course of the disease, revealed its significant influence on gene expression profile suggesting that BRAF(+)PTCs represent a molecular subtype of PTC. However, the human material disables distinction of possible molecular causes of cancer from its effects, unlike the mouse model. The main goal of our project was to find genes ...

ea0049ep1420 | Thyroid (non-cancer) | ECE2017

Prognostic value of preoperative serum calcitonin concentration on primary surgery outcomes in medullary thyroid cancer

Gawlik Tomasz , Kukulska Aleksandra , Wygoda Zbigniew , Krajewska Jolanta , Stobiecka Ewa , Czarniecka Agnieszka , Jarzab Barbara

Calcitonin assessment in thyroid diseases is recommended when medullary thyroid cancer (MTC) is suspected in fine needle biopsy, as well as in ‘suspicious for a follicular neoplasm’ class, especially oxyphilic type, in patients with germinal RET proto-oncogene mutation and in nondiagnostic biopsy when no surgical treatment is planned. This assessment is also suggested before any planned thyroid surgery to exclude MTC. Beyond diagnosis confirmation it is also suggeste...

ea0041gp198 | Thyroid - Basic | ECE2016

Differences in gene–gene interactions in Graves’ disease patients stratified by the age of diagnosis

Jurecka-Lubieniecka Beata , Bednarczuk Tomasz , Ploski Rafal , Kula Dorota , Tukiendorf Andrzej , Kolosza Zofia , Jarzab Barbara

Background: The genetic predisposition of Graves’ disease (GD) was proved by the identification of genes with substantial, non-interactive effects on the disease process. It is known, however, that genetic interactions significantly increase the likelihood of immune-tolerance-related complex diseases like allergic asthma and rheumatoid arthritis. In the present study we analyzed the effects of interactions of multiple loci on the genetic predisposition to GD patients....

ea0032p216 | Clinical case reports – Pituitary/Adrenal | ECE2013

Long-term treatment with octreotide in a patient with malignant pheochromocytoma: impact on survival and time to tumor progression

Gruszka Anna , Zieleniewski Wojciech , Kotecka-Blicharz Agnieszka , Jarzab Barbara , Kunert-Radek Jolanta

Introduction: Pheochromocytomas are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla. Approximately 10% of all pheochromocytomas are malignant. There is no effective therapy for malignant pheochromocytoma (MAL-PHEO) and the overall prognosis is poor.Case report: We report 22-year survival with MAL-PHEO in a patient treated with several surgeries, 131I-metaiodobenzylguanidine and, subsequently, with long-acting fo...